News Desk
Psychedelic Science
Every PSA story filed under the Psychedelic Science desk.
Study Finds Psychedelic Decriminalization Linked to Improved Wellbeing and Reduced Harm
As the race for FDA-approved psychedelics heats up, advocates argue decriminalization won’t undercut pharmaceutical profit margins
Can Massachusetts Lead The World In Psychedelic Opioid Treatment?
Lawmakers advance competing psychedelic therapy bills, are poised to weigh landmark programs for ibogaine and psilocybin
New Mexico to Accelerate Its Launch of Therapeutic Psilocybin Access
Community Leaders and Psychedelic Science Funders Collaborative (PSFC) Members React
When Psychedelics Meet an Injured Spinal Cord, What Really Happens?
In people with spinal cord injury (SCI), something different can happen when taking serotonergic psychedelics like psilocybin or LSD: an intense peripheral reaction in the body that can look a lot like a mild or localized form of serotonin…
Crossing the Threshold: The Art & Science of Transliminality
We often talk about liminal spaces — those mysterious in-between moments of change and transformation. But there’s a another concept from psychology that takes this idea inward: transliminality.
Expanding Public Consciousness Around Psychedelics
As the second wave of psychedelics pushes ashore, something integral is missing.
PSA Profiles: Citizen Psychedelia: A Q+A With Billerica, Massachusetts Plant Medicine Advocate Tim Morris
“I felt obligated to personally do something to help push decriminalization, and to tell people that psychedelics are nothing to be afraid of.”
PSA Profiles: Finding The Intersectional Threads Of The Psychedelic Renaissance
An interview with Entheogen Melanin Collective Co-Founder Julian Fox